Lexicon (NASDAQ: LXRX) SVP nets shares after RSU vesting on Feb 28
Rhea-AI Filing Summary
LEXICON PHARMACEUTICALS, INC. senior vice president of Discovery, Suma Gopinathan, reported multiple equity compensation transactions. On February 28, 2026, she acquired common stock through the exercise and conversion of restricted stock units in blocks of 14,000, 20,310 and 65,640 shares, each at a conversion price of $0.0000 per share. A separate transaction disposed of 24,338 shares of common stock at $1.4700 per share to cover tax withholding obligations, leaving her with 150,132 directly held common shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 75,612 shares
Net Buy
7 txns
Insider
Gopinathan Suma
Role
SVP, Discovery
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 14,000 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 20,310 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 65,640 | $0.00 | $0.00 |
| Exercise | Common Stock | 14,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 20,310 | $0.00 | $0.00 |
| Exercise | Common Stock | 65,640 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 24,338 | $1.47 | $36K |
Holdings After Transaction:
Restricted Stock Units — 151,590 shares (Direct);
Common Stock — 150,132 shares (Direct)
Footnotes (3)
- F1. Each restricted stock unit represents a contingent right to receive one share of common stock.
- F2. Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- F3. Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider activity did Lexicon Pharmaceuticals (LXRX) report for Suma Gopinathan?
Lexicon Pharmaceuticals reported that SVP, Discovery, Suma Gopinathan exercised and converted restricted stock units into common shares and had a portion of the resulting stock withheld to satisfy tax obligations, as disclosed in a Form 4 insider trading report.
How many Lexicon (LXRX) restricted stock units did Suma Gopinathan convert?
Suma Gopinathan converted restricted stock units into common stock in three blocks of 14,000, 20,310 and 65,640 units. Each restricted stock unit represents a contingent right to receive one share of Lexicon Pharmaceuticals common stock, according to the filing footnotes.
How do Lexicon (LXRX) restricted stock units vest for Suma Gopinathan?
Restricted stock units for Suma Gopinathan vest in three equal installments. One-third of the shares underlying each award vest on February 28 of each of the three years following the year of grant, according to the footnotes in the Form 4 filing.
Does the Lexicon (LXRX) Form 4 show a market purchase or sale by Suma Gopinathan?
The Form 4 shows derivative exercises and a tax-withholding disposition, not an open-market trade. The transactions are coded as option-like conversions (code M) and a tax-related share withholding (code F) linked to restricted stock unit vesting.